Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
0.7130
-0.0291 (-3.92%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Nautilus Biotechnology Stock Forecast
NAUT's stock price has decreased by -71.37% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Nautilus Biotechnology stock have an average target of 3.58, with a low estimate of 1.75 and a high estimate of 6.00. The average target predicts an increase of 402.10% from the current stock price of 0.71.
Analyst Consensus: Hold
* Price targets were last updated on Dec 5, 2024.
Analyst Ratings
The average analyst rating for Nautilus Biotechnology stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $2.25 → $1.75 | Hold → Strong Sell | Downgrades | $2.25 → $1.75 | +145.44% | Dec 5, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +741.51% | Jun 27, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +320.76% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +741.51% | Aug 3, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +741.51% | Aug 3, 2022 |
Financial Forecast
Revenue This Year
n/a
from 67.12M
Revenue Next Year
n/a
EPS This Year
-0.60
from -0.56
EPS Next Year
-0.73
from -0.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | 7.5M | 33.0M | ||
| Avg | n/a | 3.0M | 19.5M | ||
| Low | n/a | n/a | 10.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 998.4% | ||
| Avg | - | - | 550.4% | ||
| Low | - | - | 242.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.58 | -0.64 | -0.60 |
| Avg | -0.60 | -0.73 | -0.67 |
| Low | -0.66 | -0.82 | -0.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.